Cardiac Dimensions® Inc. Receives 2009 Best of Kirkland Award
7-14-09 10:30 AM EST
)
KIRKLAND, Wash.--(BUSINESS WIRE)--For the second consecutive year, Cardiac Dimensions® Inc. has been selected for the Best of Kirkland Award in the Medical Supplies category by the U.S. Local Business Association (USLBA). The award program recognizes outstanding local businesses throughout the country that have achieved exceptional marketing success and have enhanced the positive image of small business through service to their customers and community.
Only 1.4% of 2008 award recipients qualified as repeat award winners in 2009. The USLBA focused on company quality in determining their 2009 award recipients. Winners were determined based on market information gathered by USLBA and third parties.
“We are extremely pleased to receive this award for two consecutive years,” stated Tom Douthitt, Vice President of Market Development for Cardiac Dimensions®. “It is a reflection of the hard work and dedication of our entire company. Over the past few years, we have completed two clinical studies for the CARILLON® Mitral Contour System™--a medical product that we hope will revolutionize the treatment of heart failure. In addition, we have obtained ISO certification as a measure of our commitment to quality, and in January we received approval to market our product in Europe.”
Cardiac Dimensions® is a privately-held company developing a percutaneous therapy for mitral valve repair. The CARILLON® Mitral Contour System™ is designed for percutaneous treatment of Functional Mitral Regurgitation (FMR). FMR results when the valve leaflets are pulled apart by the growing heart, and do not close properly. This leads to a significant reduction in the volume of oxygenated blood channeled from the heart to the rest of the body. Since 85 percent of heart failure patients experience heart enlargement, FMR is a common condition among these patients. FMR Patients are short of breath, fatigued, and experience a significant reduction in their quality of life as they become less and less mobile. The CARILLON® system may offer a minimally invasive alternative to these patients who, up until now, have had limited treatment options. The CARILLON® system is delivered via a catheter inserted through the jugular vein and guided into the heart. The implant is placed around the valve and is tightened in order to facilitate proper closing of the mitral valve leaflets.
Approximately 5 million people in the U.S. and over 20 million people worldwide suffer from Heart Failure. Most of these patients also suffer from dilated cardiomyopathy and functional mitral regurgitation (FMR); the majority of whom are inadequately treated using medical management. While surgical options exist and can be effective in reducing FMR, they are infrequently used due to the burden of the surgery itself, which can be associated with high operative morbidity and mortality rates.
The CARILLON™ Mitral Contour System™ combines a proprietary implantable device and delivery system. The implant consists of a shaping ribbon between distal and proximal anchors. It is delivered percutaneously via jugular vein access under fluoroscopic guidance. The implant is designed to be positioned, adjusted and gently anchored in the coronary sinus/great cardiac vein to reshape the annulus around the mitral valve, thereby reducing mitral regurgitation. Preclinical and early clinical data have suggested both a reduction in mitral regurgitation and improvements in other key parameters including NYHA class, 6 Minute Walk distances, and Quality of Life.
Cardiac Dimensions®, Inc., based in Kirkland, Washington, develops and manufactures devices designed for treating heart failure and related conditions.
For further information contact Tom Douthitt at (425) 605-5900 or visit Cardiac Dimensions®, Inc. website at www.cardiacdimensions.com
Cardiac Dimensions, Inc.
Tom Douthitt, 425-605-5900
www.cardiacdimensions.com